Welcome to kongre.net
Speaker
Senior Director - Translational Gene Editing, Eli Lilly
John Moore, Senior Director - Translational Gene Editing at Eli Lilly, spoke at 7th Genome Editing Therapeutics Summit 2026 (Boston, United States of America, 29–30 Sept 2026) in the session “Workshop A: Navigating Regulatory IND Packages to Accelerate Genome Editing Therapeutics into the Clinic”.
29–30 Sept 2026Boston, United States of America
Senior Vice President, Research, Metagenomi Therapeutics
Associate Director, Sanofi
Senior Scientist, AbbVie
Senior Director, Scribe Therapeutics
Senior Director, Technical Operations, eGenesis Bio
Senior Director, Clinical Bioanalytics & Translational Science, Beam Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by John Moore, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].